Massive pulmonary embolism – what you may be missing?

Authors

  • Karun S. Sam Department of Medicine, Sir Ganga Ram Hospital, Delhi, India
  • Atul Gogia Department of Medicine, Sir Ganga Ram Hospital, Delhi, India
  • Tanvi Batra Department of Medicine, Sir Ganga Ram Hospital, Delhi, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20233051

Keywords:

Extrapulmonary tuberculosis, Pulmonary embolism, Pyrexia of unknown origin

Abstract

Our patient is a 68-year-old woman with no known comorbid illnesses, who presented with fever, cough and haemoptysis of 20-days duration. The fever was insidious in onset, intermittent, high grade and was associated with productive cough. There were intermittent episodes of scoughing up of blood-tinged sputum mixed with clots. She was evaluated at another centre and was diagnosed with a pulmonary embolism based on a computed tomographic imaging of the thorax. When she presentation to us, she was hemodynamically stable and her systemic examination was within normal limits. Her computed tomography (CT) scan were reviewed and she was labelled to have an intermediate risk pulmonary embolism. She was initiated on Injection enoxaparin and was simultaneously evaluated for the aetiology of her illness wherein an USG guided supraclavicular lymph node biopsy lead to a diagnosis of extrapulmonary tuberculosis. She was initiated on first line ATT and was discharged on the same. Anticoagulation was continued on discharge. She is currently doing well on follow up. Our objective is to shed light on the association between tuberculosis and pulmonary embolism and to emphasize the need for a thorough evaluation to identify an occult infective focus in patients presenting with venous thromboembolism.

References

Freund Y, Cohen-Aubart F, Bloom B. Acute Pulmonary Embolism: A Review. JAMA. 2022;328(13):1336-45.

Shah IK, Merfeld JM, Chun J, Tak T. Pathophysiology and Management of Pulmonary Embolism. Int J Angiol. 2022;31(3):143-9.

Moran TJ. Autopsy incidence of pulmonary embolism in tuberculosis. Dis Chest. 1950;18(2):171-3.

Ha H, Kim KH, Park JH, Lee JK, Heo EY, Kim JS, et al. Thromboembolism in Mycobacterium tuberculosis Infection: Analysis and Literature Review. Infect Chemother. 2019;5:142-9.

Robson SC, White NW, Aronson I, Woollgar R, Goodman H, Jacobs P.Acute-phase response and the hypercoagulable state in pulmonary tuberculosis. Br J Haematol. 1996;93:943-9.

Gogna A, Pradhan GR, Sinha RS. Tuberculosis presenting as deep vein thrombosis. Postgrad Med J. 1999;75:104-5.

Gupta A, Mrigpuri P, Faye A, Bandyopadhyay D, Singla R: Pulmonary tuberculosis-an emerging risk factor for venous thromboembolism: a case series and review of literature. Lung India. 2017;34:65-9.

Krishnan N, Robertson BD, Thwaites G. The mechanisms and consequences of the extra-pulmonary dissemination of Mycobacterium tuberculosis. Tuberculosis. 2010;90:361-6.

Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing GJ, Harjola VP, et al; ESC Scientific Document Group. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J. 2020;41:543-603.

White NW. Venous thrombosis and rifampicin. Lancet. 1989;334:434-5.

Downloads

Published

2023-09-29

How to Cite

Sam, K. S., Gogia, A., & Batra, T. (2023). Massive pulmonary embolism – what you may be missing?. International Journal of Research in Medical Sciences, 11(10), 3876–3879. https://doi.org/10.18203/2320-6012.ijrms20233051

Issue

Section

Case Reports